Clinical Trial: A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525375) titled 'A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma' on April 07.

Brief Summary: The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

Study Start Date: April 15

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: COMBINATION_PRODUCT: GP MDI

GP MDI will be administered via oral inhalation twice daily (BID)....